Significant Ownership of Bios Equity Partners, LP

Signature - Title
/s/ John Fucci - John Fucci/Attorney-in-Fact
Location
Fort Worth, TX
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Bios Equity Partners, LP.

Notify me when Bios Equity Partners, LP files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Bios Equity Partners, LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
LTRN Lantern Pharma Inc. Common Stock, par value $0.0001 per share 8.6% $2,908,879 -$351,256 960,026 -11% BIOS CAPITAL MANAGEMENT, LP 20 Feb 2026

Schedules 13D/G Reported by Bios Equity Partners, LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.